Mednax Inc (MD)

Operating return on assets (Operating ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 146,253 -4,528 1,917 1,652 7,321 174,828 181,943 183,600 192,667 204,655 216,061 215,922 202,918 167,218 128,884 113,776 100,790 133,236 -1,246,983 -1,201,391
Total assets US$ in thousands 2,152,700 2,076,870 1,995,350 2,168,160 2,219,810 2,326,340 2,305,510 2,320,050 2,347,890 2,331,960 2,369,620 2,340,980 2,722,550 2,646,100 2,555,130 2,483,740 3,347,950 3,424,830 3,387,210 4,319,660
Operating ROA 6.79% -0.22% 0.10% 0.08% 0.33% 7.52% 7.89% 7.91% 8.21% 8.78% 9.12% 9.22% 7.45% 6.32% 5.04% 4.58% 3.01% 3.89% -36.81% -27.81%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $146,253K ÷ $2,152,700K
= 6.79%

Mednax Inc's operating return on assets (ROA) has shown significant fluctuations over the quarters analyzed. The operating ROA started at a negative level in March 2020 and June 2020, indicating that the company was not generating profits from its operational activities efficiently in those quarters. However, there was a significant improvement in September 2020 when the operating ROA turned positive, reaching 3.89%.

From December 2020 to June 2022, Mednax Inc continued to improve its operating ROA steadily, with consistent increases quarter over quarter. The operating ROA reached its peak at 9.22% in March 2022. This indicates that the company was effectively utilizing its assets to generate operating profits during this period.

However, from September 2022 to December 2024, there was a slight decline in the operating ROA, though it remained positive for the most part. The fluctuation in the operating ROA during this period suggests some variability in the company's operational efficiency and profitability.

Notably, there was a significant drop in the operating ROA to -0.22% in September 2024, indicating that the company's operating profits were insufficient to cover its asset base in that quarter. The operating ROA recovered in the following quarter, reaching 6.79% in December 2024.

Overall, Mednax Inc's operating ROA showed both positive and negative trends over the quarters analyzed, indicating fluctuations in the company's operational performance and efficiency in utilizing its assets to generate profits.


Peer comparison

Dec 31, 2024

Company name
Symbol
Operating ROA
Mednax Inc
MD
6.79%
Encompass Health Corp
EHC
13.23%
Select Medical Holdings
SEM
4.75%